This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Gabapentin: Difference between revisions
Jump to navigation
Jump to search
>Isaak Common names correctly annotated. |
>Isaak Annotate bioavailability correctly |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 54: | Line 54: | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability=27% - 60%<ref> | |OralROA_Bioavailability=[[Oral min bioavailability::27]]% - [[Oral max bioavailability::60]]%<ref name="NeurotoninMedScape">{{Citation | title=Neurontin, Gralise (gabapentin) dosing, indications, interactions, adverse effects, and more | url=https://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011}}</ref> | ||
|OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]] | |OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg | |OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg | ||
| Line 64: | Line 64: | ||
|OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::10]] [[Oral total time units::hours]] | |OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::10]] [[Oral total time units::hours]] | ||
|OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::120]] [[Oral onset time units::minutes]] | |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::120]] [[Oral onset time units::minutes]] | ||
|OralROA_Peak=[[Oral min peak time::120]] - [[Oral max peak time::180]] [[Oral | |OralROA_Peak=[[Oral min peak time::120]] - [[Oral max peak time::180]] [[Oral peak time units::minutes]] | ||
|OralROA_Offset= | |OralROA_Offset= | ||
|OralROA_Aftereffects= | |OralROA_Aftereffects= | ||
}} | }} | ||
Latest revision as of 06:32, 13 October 2022
| SubstanceBox/Gabapentin | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||
| Common names | Gabapentin, Neurontin, Gabarone, Gralise | ||||||||||||||||||||||||||||
| Substitutive name | Gabapentin | ||||||||||||||||||||||||||||
| Systematic name | 1-(Aminomethyl)cyclohexaneacetic acid | ||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||
| Psychoactive class | Depressant | ||||||||||||||||||||||||||||
| Chemical class | Gabapentinoid | ||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||